Company news

Bone Biologics Corp news in 2024

Bone Biologics Corp's news releases, calls and decks from 2024, newest first.

View company

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

October 20, 2024

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

August 1, 2024

First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion

June 19, 2024

Bone Biologics Announces Closing of $2.0 Million Public Offering

March 6, 2024

Bone Biologics Announces Pricing of $2.0 Million Public Offering

March 3, 2024

Bone Biologics Reports Progress With NB1 Clinical Program

February 29, 2024

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

January 10, 2024

Decks in 2024